Skip to content

Regenicin, Inc.: 10-Q filed 2020-08-19

What Regenicin, Inc. reported in its quarterly report filed 2020-08-19 (fiscal Q3 2020): 18 published measures, 57 facts as tagged in accession 0001662252-20-000073.

This filing

Form
10-Q (quarterly report)
Filed
2020-08-19
Fiscal period
fiscal Q3 2020
Accession
0001662252-20-000073 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Regenicin, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-303,104USD
At 2019-09-305,315USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-30-4,286,157USD
At 2020-03-31-4,114,319USD
At 2019-12-31-3,925,671USD
At 2019-09-30-3,727,685USD
At 2019-06-30-3,727,685USD
At 2019-03-31-3,394,886USD
At 2018-12-31-3,216,535USD
At 2018-09-30-3,000,053USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-06-301,404USD
At 2019-09-30815USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30171,838USD91
2019-10-01 to 2020-06-30558,472USD274
2020-01-01 to 2020-03-31-188,648USD91
2019-10-01 to 2019-12-31-197,986USD92
2019-04-01 to 2019-06-30182,871USD91
2018-10-01 to 2019-06-30608,528USD273
2019-01-01 to 2019-03-31-178,351USD90
2018-10-01 to 2018-12-31-247,306USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-10-01 to 2020-06-30-96,961USD274
2018-10-01 to 2019-06-30-116,970USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-10-01 to 2020-06-3097,550USD274
2018-10-01 to 2019-06-30115,975USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-14,648,867USD
At 2019-09-30-14,090,395USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2018-10-01 to 2019-06-3030,824USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-162,054USD91
2019-10-01 to 2020-06-30-517,262USD274
2019-04-01 to 2019-06-30-176,234USD91
2018-10-01 to 2019-06-30-591,387USD273

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-04-01 to 2020-06-308,559USD91
2019-10-01 to 2020-06-3038,410USD274
2019-04-01 to 2019-06-304,362USD91
2018-10-01 to 2019-06-3013,541USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-304,289,261USD
At 2019-09-303,733,000USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-06-30122,847USD
At 2019-09-30138,298USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-30162,054USD91
2019-10-01 to 2020-06-30517,262USD274
2019-04-01 to 2019-06-30176,234USD91
2018-10-01 to 2019-06-30591,387USD273

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-06-3010,208,339USD
At 2019-09-3010,208,339USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2020-06-30-4,286,157USD
At 2019-09-30-3,727,685USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-06-30309,545USD
At 2019-09-30271,133USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-189,489USD91
2019-10-01 to 2020-06-30-611,619USD274
2019-04-01 to 2019-06-30-200,522USD91
2018-10-01 to 2019-06-30-661,482USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30162,054USD91
2019-10-01 to 2020-06-30517,262USD274
2019-04-01 to 2019-06-30176,234USD91
2018-10-01 to 2019-06-30560,563USD273

Inspect the source

Entity
Regenicin, Inc. / CIK 0001412659
Captured
SEC response SHA-256
66d33e554adc1e643294d5e778c52aa5121a74d07c71bf640453c952267c0d14

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001412659.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))